Correlation Between Ligand Pharms and Alphabet

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ligand Pharms and Alphabet at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ligand Pharms and Alphabet into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ligand Pharms Glucagon and Alphabet Inc Class C, you can compare the effects of market volatilities on Ligand Pharms and Alphabet and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ligand Pharms with a short position of Alphabet. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ligand Pharms and Alphabet.

Diversification Opportunities for Ligand Pharms and Alphabet

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ligand and Alphabet is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Ligand Pharms Glucagon and Alphabet Inc Class C in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alphabet Class C and Ligand Pharms is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ligand Pharms Glucagon are associated (or correlated) with Alphabet. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alphabet Class C has no effect on the direction of Ligand Pharms i.e., Ligand Pharms and Alphabet go up and down completely randomly.

Pair Corralation between Ligand Pharms and Alphabet

Assuming the 90 days horizon Ligand Pharms Glucagon is expected to generate 31.48 times more return on investment than Alphabet. However, Ligand Pharms is 31.48 times more volatile than Alphabet Inc Class C. It trades about 0.71 of its potential returns per unit of risk. Alphabet Inc Class C is currently generating about 0.23 per unit of risk. If you would invest  0.19  in Ligand Pharms Glucagon on January 26, 2024 and sell it today you would earn a total of  0.11  from holding Ligand Pharms Glucagon or generate 57.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy9.52%
ValuesDaily Returns

Ligand Pharms Glucagon  vs.  Alphabet Inc Class C

 Performance 
       Timeline  
Ligand Pharms Glucagon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Solid
Over the last 90 days Ligand Pharms Glucagon has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Ligand Pharms showed solid returns over the last few months and may actually be approaching a breakup point.
Alphabet Class C 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Alphabet Inc Class C are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Alphabet is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Ligand Pharms and Alphabet Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ligand Pharms and Alphabet

The main advantage of trading using opposite Ligand Pharms and Alphabet positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ligand Pharms position performs unexpectedly, Alphabet can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alphabet will offset losses from the drop in Alphabet's long position.
The idea behind Ligand Pharms Glucagon and Alphabet Inc Class C pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum